Multiple interacting gene products may influence susceptibility to malignant hyperthermia

Annals of Human Genetics

Volumn 64, Issue 4, 2000, Pages 307-320

  Robinson, R L ^a,b   Curran, J L ^a,b   Ellis, F R ^b   Halsall, P J ^b   Hall, W J ^b   Hopkins, P M ^b   Iles, D E ^a   West, S P ^c   Shaw, M A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CALCIUM; GENE PRODUCT;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; DISEASE PREDISPOSITION; FEMALE; GENETIC DISORDER; GENETIC MODEL; GENETIC VARIABILITY; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTHERMIA; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANESTHETICS, INHALATION; CALCIUM SIGNALING; CHROMOSOMES, HUMAN; FEMALE; GENETIC MARKERS; GENOTYPE; HUMAN; LINKAGE DISEQUILIBRIUM; MALE; MALIGNANT HYPERTHERMIA; MUSCLE, SKELETAL; PEDIGREE; PHENOTYPE; SUPPORT, NON-U.S. GOV'T; VARIATION (GENETICS); HUMANS;

EID: 0033782713     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-1809.2000.6440307.x     Document Type: Article

References (74)

1. The G1021 A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia in a British pedigree
2. The genetics of malignant hyperthermia
3. Multiple significance tests : The Bonferroni method
4. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: Novel mutations and concordance with the in vitro contracture test
5. Molecular basis of myotonic dystrophy-expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member
6. Malignant hyperthermia: Relationship to other diseases
7. Genetic evidence for the neuronal nitric oxide synthase gene (NOS1) as a susceptibility locus for infantile pyloric stenosis
8. Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity
9. Linkage disequilibrium mapping of type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-33
10. Segregation of malignant hyperthermia, central core disease and chromosome 19 markers
11. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility
12. Discordance in a malignant hyperthermia pedigree, between the in vitro contracture test phenotypes and haplotypes for the MHS1 region of chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene
13. A comprehensive genetic map of the human genome based on 5264 microsatellites
14. Dinucleotide repeat polymorphism in human IL1A gene
15. A protocol for the investigation of malignant hyperthermia susceptibility
16. Malignant hyperthermia susceptibility, an autosomal dominant disorder?
17. Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation
18. Rapid detection of CA polymorphisms in cloned cDNA : Application to the 5' region of the Dystrophin gene
19. Identification of a mutation in the porcine ryanodine receptor that is associated with malignant hyperthermia
20. Substitution of cysteine for argenine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia
21. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor gone (RYR1) in individuals with malignant hyperthermia
22. Assignment of the human gene for the α1-subunit of the skeletal muscle DHP-sensitive Ca(2 +) channel (CACNA1S) to chromosome 1q31-q32
23. Linkage analysis of 'necessary' disease loci versus 'susceptibility' loci
24. The power to detect linkage in complex disease by means of simple LOD-score analyses
25. Aetiology of malignant hyperthermia
26. The 1993-1994 genethon human genetic linkage
27. Screening for malignant hyperthermia susceptibility
28. Central core disease and malignant hyperthermia are not always associated
29. Efficiency of typing unaffected relatives in an affected sib-pair linkage study with single locus and multiple tightly linked markers
30. Asymptotic properties of affected sib-pair linkage analysis
31. High-resolution physical mapping of four microsatellite repeat markers near the RYR1 locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families
32. Genetic mapping of the β1- and γ-subunits of the human skeletal muscle L-type voltage dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility
33. Localisation of the gene encoding the α2/δ subunits of the L-type voltage dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families
34. Linkage disequilibrium as a gene mapping tool
35. Detection of a novel RYR1 mutation in four malignant hyperthermia families
36. Strategies for multilocus linkage analysis in humans
37. Construction of human genetic linkage maps : Likelihood calculations for multilocus analysis
38. Mapping of the gene for hormone sensitive lipase (LIPE) to chromosome 19q13.1-13.2
39. Evidence for the localisation of a malignant hyperthermia susceptibility locus (MHS2) to chromosome 17q
40. Identification of heterozygous and homozygous individuals with the novel RYR1 mutation Cys35Arg in a large kindred
41. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia
42. Identification of novel mutations in the ryanodine receptor gene (RYR1) in malignant hyperthermia : Genotype-phenotype correlation
43. Localisation of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2
44. The genetics of malignant hyperthermia: Evidence for heterogeneity
45. 2+ release channels and their regulation by endogenous effectors
46. 2+ regulation defects
47. Malignant hyperthermia susceptibility is associated with a mutation of the α1-subunit of the dihydropyridine sensitive L-type voltage dependent calcium channel receptor in skeletal muscle
48. Diagnosis of susceptibility to malignant hyperthermia in man
49. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH group : Results of testing patients surviving fulminant MH and unrelated low-risk subjects
50. 2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia
51. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia
52. Mutation screening of the RYR1 gene in malignant hyperthermia : Detection of a novel Tyr to Ser mutation in a pedigree with associated central cores
53. The future of genetic studies of complex human diseases
54. Functional characterisation of a distinct ryanodine receptor mutation in Human malignant hyperthermia-susceptible muscle
55. Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families
56. A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees
57. Clinical presentation of malignant hyperthermia
58. Linkage and association between insulin-dependent diabetes mellitus (IDDM) susceptibility and markers near the glucokinase gene on chromosome 7
59. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci
60. Monogenic traits are not so simple
61. Transmission disequilibrium test for linkage disequilibrium
62. Malignant Hyperthermia : A review of published cases
63. Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the α1-, β1-, and γ-subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect
64. Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1
65. Handbook of human genetic linkage
66. The genetics of complex diseases
67. 2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease
68. Polygenic disease : Methods for mapping disease traits
69. A second generation map of the Human genome
70. A complex satellite DNA polymorphism flanking the human ryanodine receptor gone RYR1
71. A mutation in the human ryanodine receptor gene associated with central core disease